Key result
Sequential AV-synchronous leadless pacemaker implantation alongside a depleted device maintains ~85% AV synchrony at six months.
Why the study?
Clinical data on long-term management and sequential implantation strategies after battery depletion in patients with leadless pacemakers remain limited.
Does a sequential leadless-only pacing strategy (leave-in-situ approach) provide a safe and feasible option for battery depletion in a patient with recurrent device-related infections?
Case Report (n=1)
No
Does a sequential leadless-only pacing strategy (leave-in-situ approach) provide a safe and feasible option for battery depletion in a patient with recurrent device-related infections?
Sequential implantation of a new leadless pacemaker while leaving a depleted device in situ is a feasible and safe strategy for pacemaker-dependent patients at high risk of infection.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice in high-risk patients; leaves open sequential leave-in-situ leadless pacing after battery depletion.
Chinybayeva et al. (2026) conducted a case report in Battery depletion of leadless pacemaker with recurrent device-related infection (n=1). Sequential leadless pacing (Micra AV implantation with leave-in-situ of Micra VR) was evaluated on Feasibility, safety, and electrical parameters (pacing threshold, impedance, AV synchrony). Sequential implantation of an AV-synchronous leadless pacemaker while leaving a depleted device in situ was safe and feasible, maintaining stable electrical parameters and 85% atrioventricular synchrony at 6 months without mechanical interaction or infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: